Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.

Edgar Engleman, M.D.

Stanford University # of Grants: 1


Mobilized dendritic cells for lung cancer 2000 (Cycle 9) $950,821
Cancer Research Project Awards

In vivo manipulation of dendritic cells to induce therapeutic immunity
Periodical: Blood Index Medicus:
Authors: Merad, M, Sugie, T., Engleman, E.G. and Fong, L. ART
Yr: 2002 Vol: 99 Nbr: Abs: Pg: 1676-1682

Langerhans cells renew in the skin throughout life under steady-state conditions.
Periodical: Nature Immunology Index Medicus:
Authors: Merad M, Manz MG, Karsunky H, Wagers A, Peters W, Charo I, Weissman IL, Cyster JG, Englema ART
Yr: 2002 Vol: 3 Nbr: Abs: Pg: 1135-1141

Dendritic cell-based cancer immunotherapy.
Periodical: Seminars in Oncology Index Medicus:
Authors: Engleman EG ART
Yr: 2003 Vol: 30 Nbr: Abs: Pg: 23-29

Induction of immunity to tumor-associated antigens following dendritic cell vaccination of cancer patients.
Periodical: Clinical Immunology Index Medicus:
Authors: Engleman EG, Fong L ART
Yr: 2003 Vol: 106 Nbr: Abs: Pg: 10-15

Induction of potent antitumor immunity by in situ targeting of intratumoral DCs.
Periodical: Journal of Clinical Investigation Index Medicus:
Authors: Furumoto K, Soares L, Engleman EG, Merad M ART
Yr: 2004 Vol: 113 Nbr: Abs: Pg: 774-783

DC-based cancer vaccines: lessons from clinical trials.
Periodical: Cytotherapy Index Medicus:
Authors: Brody J, Engleman EG ART
Yr: 2004 Vol: 6 Nbr: Abs: Pg: 122-127